UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 187

Sortiert nach

The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

Journal of thoracic oncology, 2022-03, Vol.17 (3), p.362-387

2022

Link zum Volltext

Verfügbarkeit prüfen

Programmed Death Ligand-1 Immunohistochemistry: Friend or Foe?

Archives of pathology & laboratory medicine (1976), 2016-04, Vol.140 (4), p.326-331

2016

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Journal of thoracic oncology, 2017-02, Vol.12 (2), p.208-222

2017

Link zum Volltext

Verfügbarkeit prüfen

Non-Small Cell Lung Cancer, PD-L1, and the Pathologist

Archives of pathology & laboratory medicine (1976), 2016-03, Vol.140 (3), p.249-254

2016

Link zum Volltext

Verfügbarkeit prüfen

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2017-12, Vol.35 (34), p.3867-3876

2017

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1302-1311

2018

Link zum Volltext

Verfügbarkeit prüfen

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma

Thorax, 2018-03, Vol.73 (Suppl 1), p.i1

2018

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary adenocarcinomas: classification and reporting

Histopathology, 2009-01, Vol.54 (1), p.12-27

Kerr, Keith M

2009

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification

Archives of pathology & laboratory medicine (1976), 2013-05, Vol.137 (5), p.668-684

2013

Link zum Volltext

Verfügbarkeit prüfen

Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

Journal of thoracic oncology, 2022-12, Vol.17 (12), p.1335-1354

2022

Link zum Volltext

Verfügbarkeit prüfen

The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer

Health technology assessment (Winchester, England), 2016-05, Vol.20 (40), p.1-146

2016

Link zum Volltext

Verfügbarkeit prüfen

Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach

The oncologist (Dayton, Ohio), 2021-02, Vol.26 (2), p.e306-e315

2021

Link zum Volltext

Verfügbarkeit prüfen

Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2016-04, Vol.140 (4), p.341-344

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular testing in stage I–III non-small cell lung cancer: Approaches and challenges

Lung cancer (Amsterdam, Netherlands), 2021-12, Vol.162, p.42-53

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification

Journal of clinical pathology, 2013-10, Vol.66 (10), p.832-838

Kerr, Keith M

2013

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma

PloS one, 2011-06, Vol.6 (6), p.e21443-e21443

2011

Link zum Volltext

Verfügbarkeit prüfen

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

Journal of thoracic oncology, 2010-10, Vol.5 (10), p.1706-1713

2010

Link zum Volltext

Verfügbarkeit prüfen

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group

Lung cancer (Amsterdam, Netherlands), 2012-04, Vol.76 (1), p.1-18

2012

Link zum Volltext

Verfügbarkeit prüfen

Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens

Journal of thoracic oncology, 2010-04, Vol.5 (4), p.442-447

2010

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification

Archives of pathology & laboratory medicine (1976), 2013-05, Vol.137 (5), p.685-705

2013

Link zum Volltext

Verfügbarkeit prüfen

The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.686-696

2021

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

Nature reviews. Clinical oncology, 2021-06, Vol.18 (6), p.345-362

2021

Link zum Volltext

Verfügbarkeit prüfen

The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?

Journal of thoracic oncology, 2018-03, Vol.13 (3), p.291-294

Kerr, Keith M.

2018

Link zum Volltext

Verfügbarkeit prüfen

Personalized medicine for lung cancer: new challenges for pathology

Histopathology, 2012-03, Vol.60 (4), p.531-546

Kerr, Keith M

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 187

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(161)

Publikationsform

Artikel
(187)

Sprache

Englisch
(187)
Japanisch
(52)

Erscheinungsjahr

n.n

Thema

Science & Technology
(179)
Life Sciences & Biomedicine
(172)
Oncology
(76)
Female
(74)
Male
(67)
Respiratory System
(53)
Lung Neoplasms - Pathology
(52)
Middle Aged
(51)
Pathology
(48)
Biological And Medical Sciences
(46)
Aged
(44)
Medical Sciences
(44)
Immunohistochemistry
(39)
Lung Cancer
(39)
Adult
(36)
Lung Neoplasms - Diagnosis
(31)
Lung Neoplasms - Genetics
(31)
Prognosis
(31)
Carcinoma, Non-Small-Cell Lung - Pathology
(26)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

Programmed Death Ligand-1 Immunohistochemistry: Friend or Foe?

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Non-Small Cell Lung Cancer, PD-L1, and the Pathologist

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma

Pulmonary adenocarcinomas: classification and reporting

Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification

Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer

Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach

Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society

Molecular testing in stage I–III non-small cell lung cancer: Approaches and challenges

Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification

DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group

Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens

Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification

The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?

Personalized medicine for lung cancer: new challenges for pathology

Aktive Filter

Suchergebnisse filtern